Consolidated Statements of Cash Flows - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020
Cash Flows from Operating Activities
Net loss		$ (169.1)	$ (298.9)
Loss from discontinued operations, net of tax		(6.5)	(14.3)
Loss from continuing operations, net of tax		(162.6)	(284.6)
Adjustments to reconcile net loss from continuing operations to net cash used by operating activities:
Depreciation		39.6	43.4
Amortization		17.6	19.3
Provision for doubtful accounts		48.5	64.2
Provision for obsolescence		20.3	28.2
Share-based compensation		7.7	21.8
Foreign exchange (gains) losses		(1.2)	3.0
Deferred income taxes		(10.5)	21.8
Impairment loss on assets		1.0	1.8
Gain on sale of business / assets		(8.3)	(1.5)
Other		(0.9)	22.1
Changes in assets and liabilities:
Accounts receivable		(51.2)	(84.0)
Inventories		(76.4)	(84.1)
Prepaid expenses and other		6.1	(9.0)
Accounts payable and accrued liabilities		(80.9)	(85.7)
Income and other taxes		(8.8)	2.8
Noncurrent assets and liabilities		(38.2)	13.9
Net cash used by operating activities of continuing operations		(298.2)	(306.6)
Cash Flows from Investing Activities
Capital expenditures		(48.2)	(30.0)
Disposal of assets		2.3	1.8
Net proceeds from sale of business / assets		13.9	11.3
Other investing activities		0.0	0.4
Net cash used by investing activities of continuing operations	[1]	(32.0)	(16.5)
Cash Flows from Financing Activities
Cash dividends		0.0	(8.6)
Debt, net (maturities of three months or less)		(5.0)	12.5
Proceeds from debt		269.9	80.8
Repayment of debt		(57.5)	(48.3)
Repayments of debt to affiliates of Natura &Co	[1]	(31.7)	0.0
Repayment of debt by affiliates of Natura &Co		49.8	0.0
Repurchase of common stock		0.0	(0.4)
Costs associated with debt issue / repayment		0.0	(3.8)
Settlement of stock options		0.0	(25.8)
Settlement of derivative contracts		(3.9)	19.5
Repayment of monetization of COFINS tax credits		(15.5)	0.0
Net cash provided by financing activities of continuing operations	[1]	206.1	25.9
Net cash used by operating activities of discontinued operations		(7.5)	(11.2)
Net cash used by discontinued operations		(7.5)	(11.2)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash		(16.5)	(23.9)
Net decrease in cash and cash equivalents, and restricted cash		(148.1)	(332.3)
Cash and cash equivalents, and restricted cash at beginning of year		373.4	661.0
Cash and cash equivalents, and restricted cash at end of period		$ 225.3	$ 328.7

[1] On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding for $150, with the proceeds used to repay maturing loans of $150 borrowed under the $250 Revolving Credit Facility with a subsidiary of Natura &Co Holding. Under the terms of the transaction and the associated Direction and Settlement Agreement, no cash flows in either investing or financing activities arose as a result of the transaction.